FDA Approval: ANZUPGO (DELGOCITINIB) — Type 1 - New Molecular Entity
Dermatology
CPT procedure code
87493
Code definition
Code
87493
Code system
CPT (Current Procedural Terminology)
This CPT code is not in our curated reference. CPT codes are maintained by the American Medical Association (AMA). Full descriptions require an AMA license.
Category
—
Short description sourced from CMS publicly available fee schedule data. Full CPT descriptions are copyright AMA. Not a substitute for the official CPT codebook.
Latest reimbursement alerts
No alerts currently reference 87493 directly. Here are the latest policy changes across all codes.
Low
FDA Approval: LEQSELVI (DEURUXOLITINIB PHOSPHATE) — Type 1 - New Molecular Entity
Dermatology
FDA Approval: ONAPGO (APOMORPHINE HYDROCHLORIDE) — Type 5 - New Formulation or New Manufacturer
Neurology
Medicare Coverage Database - New Items
General
CMS Physician Fee Schedule
Physician Fee Schedule
CMS MAC Archives
General
Related CPT codes (874xx)
Get alerts when policy changes affect 87493
Free weekly digest — no subscription required.
Look up another code
Search ICD-10, HCPCS, or CPT codes with related reimbursement alerts.